EBR Systems, Inc. (EBR.XA)
Cboe AU · AUD
A$0.1245 (-11.07%) as of
Key statistics
- 52-week range
- 0.1200 – 1.2500
- Beta
- 0.50
- Revenue (TTM)
- 6.45M
- Profit margin
- 0.00%
- Volume
- 1.18M
About EBR Systems, Inc.
EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. It offers WiSE cardiac resynchronization therapy system, an implantable cardiac pacing system able to provide stimulation to endocardial heart tissue for the correction of heart rhythm conditions without requiring the use of leads; and stimulation of the left ventricular endocardium for cardiac resynchronization therapy (SOLVE-CRT), an investigational device exemption. The company was incorporated in 2003 and is headquartered in Sunnyvale, California.
- Headquarters
- Sunnyvale, CA, United States
- Employees
- 135
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.